Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States: An Early Drug Utilization Analysis

Conference Reports for NATAP

53rd ICAAC Interscience Conference on
Antimicrobial Agents and Chemotherapy
September 10-13, 2013, Denver CO


Status of Truvada (TVD) for HIV Pre-Exposure Prophylaxis (PrEP) in the United States: An Early Drug Utilization Analysis

	ICAAC 2013 Sept 10-13 Denver Colrado RM Mera, MK Rawlings, A Pechonkina, JF Rooney, T Peschel, A Cheng Gilead Sciences, Inc., Foster City, CA